Raleigh Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-39
Closed -$253 – 660
2025
Q2
$253 Hold
39
– – ﹤0.01% 556
2025
Q1
$207 Sell
39
-6
-13% -$41 ﹤0.01% 518
2024
Q4
$378 Buy
+45
New +$347 ﹤0.01% 963

Other funds holding TBI

Raleigh Capital Management's TBI Position: Q3 2025 in Review

Raleigh Capital Management sold out of Trueblue (TBI) in Q3 2025, closing a stake of 39 shares — an estimated $253 sold.

Raleigh Capital Management first reported a position in TBI in Q4 2024 and held it in 3 quarters. The position peaked at $378 in Q4 2024. 108 funds tracked by Wall St. Rank hold TBI as of Q3 2025.

  • Raleigh Capital Management reported no remaining Trueblue position as of Q3 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 39 Trueblue shares in Q3 2025, an estimated $253.
  • Raleigh Capital Management first reported a position in Trueblue in Q4 2024 and held it in 3 quarters.
  • Raleigh Capital Management's Trueblue position peaked at $378 in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Trueblue as of Q3 2025.

Based on Raleigh Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.